GlobeNewsWire
22 Sept 2026, 12:40 UTC · 1h ago
Verdict
Headline leans bullish. We score ONMD +0.80 across three claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.80strongly bullish
What the story claims
3 claims · scored −1 bearish … +1 bullish · 2 new · 1 priced in
OneMedNet entered a 3-year subscription-based license agreement with Atropos Health that adds to its Annual Recurring Revenue (ARR).
Newpress release dated Sept. 22, 2026
So whatThe move toward ARR shifts valuation from one-time data sales to a subscription multiple, likely lifting the share price in the next print.
More positive than 92% of claims this week
Continue reading
5 related stories
More positive than 84% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Atropos Health customers can now purchase additional OneMedNet multi-modal data directly through the Atropos platform.
Newpress release dated Sept. 22, 2026
So whatThis creates a scalable resale channel for OneMedNet's 90 million patient journeys, potentially accelerating revenue growth in FY2027.
More positive than 76% of claims this week
OneMedNet currently maintains a network of over 2,300 sites with 270 million studies.
Priced incontained in 'About' section of press release
More positive than 40% of claims this week
Which stocks this story touches
More positive than 84% of ticker scores this week
The company announced a strategic multi-year partnership that increases its Annual Recurring Revenue (ARR) and expands its commercial reach.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+4.7%
Price agrees with the score
$0.7200 vs $0.6877 close before publication (Sep 21) · not market-adjusted
ONMD chart →